NCT00420602已完成不适用
Clinical Interventions Against Stargardt Macular Dystrophy: DHA Supplementation in Patients With STGD3
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 11
- 试验地点
- 2
- 主要终点
- ERG
研究概览
简要总结
We have found that biomarkers of long-term elevated dietary intake of omega-3 fatty acids such as DHA and EPA are inversely associated with severity of disease phenotype in STGD3 patients. Therefore, the purpose of this study is to follow STGD3 patients as they supplement their diets with DHA/EPA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 105 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All Moran Eye Center patients with STGD3
排除标准
- •All others
研究组 & 干预措施
Single Arm, Open Label
Other
Single Arm, Open Label
干预措施: Over the counter DHA/EPA dietary supplementation (Dietary Supplement)
结局指标
主要结局
ERG
时间窗: 1 year
次要结局
- Visual acuity(1 year)
研究者
Paul S. Bernstein
Professor of Ophthalmology
University of Utah
研究点 (2)
Loading locations...
相似试验
终止
不适用
Omega-3 Fatty Acid Supplements and Dry EyeKeratoconjunctivitis SiccaNCT01213342Ohio State University35
已完成
不适用
Essential Fatty Acids for Major DepressionMajor DepressionNCT00256412University of Iowa24
已完成
3 期
Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic AdultsDyslipidemiaNCT00422266Centre for Chronic Disease Control, India178
已完成
不适用
Epithelial Healing and Visual Outcomes Using Omega-3 Therapy Before and After Photorefractive Keratectomy (PRK) SurgeryRefractive ErrorNCT01059019University of California, San Diego17
已完成
不适用
Omega-3 Fatty Acids, the Omega-3 Index, and AtherosclerosisAtherosclerosisNCT00886704Ludwig-Maximilians - University of Munich50